MoneyWorks4Me

Godavari Drugs informs about secretarial compliance report

20 May 2026 Evaluate
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI’s Master Circular No. HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated 30th January, 2026, Godavari Drugs has informed that it enclosed the Annual Secretarial Compliance Report for the financial year 2025-26. The report will also be available on the Company’s website at www.godavaridrugs.com

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..